Phase I trial of hepatic arterial infusion of Abraxane with a pharmacokinetic study in advanced solid cancer patients with predominant hepatic metastases
Phase of Trial: Phase I
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Paclitaxel (Primary)
- Indications Cancer metastases; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 04 Feb 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 28 Oct 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Jun 2017 as per ClinicalTrials.gov record.
- 24 Oct 2013 Planned end date changed from 1 Jun 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.